Delivery Order SPE2DB20D1100-SPE2DB25FC8B9

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,553,034 units of 5 mg Methylphenidate chewable tablets in 100-count bottles. The contract has a firm fixed price of $3,789.26 and a period of performance through March 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Methylphenidate 2.5 mg chewable tablets. The contract is valued at $3,413.81 and will run until October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999, for providing a comprehensive range of medical...
This federal contract award is a delivery order with a firm fixed price of $1,149.78 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,720,827 units of Methylphenidate 5 mg chewable tablets in 100-count bottles, with a completion date of March 28, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Methylphenidate 10 mg chewable tablets in quantities of 100s. The contract has a firm fixed price and a ceiling value of $2,502.64. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,355 units of Methylphenidate 10 mg chewable tablets. The contract has a firm fixed price of $3,294.57 and runs through November 7, 2024. The contract is not designated as a set-aside. Amerisourcebergen is the prime contractor, and the contract is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,672.32 firm-fixed-price contract is for the supply of 4,567,420,120 units of Methylphenidate HCL Chew Tablets, 5mg. The delivery order has a March 3, 2025 ultimate completion date. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Methylphenidate ER 18 mg tablets. The contract has a firm fixed price of $1,913.19 and a performance period through May 21, 2025. The contract is not set aside for any special program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00, providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,023.03 and a ceiling value of $1,023.03, with a performance period ending on May 1, 2025. The contract is for the supply of 4568090353 - Methylphenidate 5 mg chew tablets in 100-count containers. This contract is not designated as a set-aside....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Methylphenidate 2.5 mg chewable tablets, with a ceiling value of $1,147.90 and a performance period through May 8, 2025. The contract is not set-aside and was awarded on May 7, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,340,677 units of Methylphenidate ER 54 mg Tablets in 100-count bottles. The Firm Fixed Price contract has a ceiling value of $3,994.02 and a completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC8B9
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 5 milligram methylphenidate chewable tablets in 100-count bottles, with a ceiling value of $3,561.77 and a performance period ending on June 11, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency, U.S. Coast Guard, and other government agencies. The methylphenidate contract is not designated as a set-aside, indicating open competition.

Generated 9/9/25, 12:55 PM